Putting Prevention into Practice
An Evidence-Based Approach
Medication Use to Reduce Risk of Breast Cancer
Am Fam Physician. 2020 Mar 15;101(6):373-374.
Author disclosure: No relevant financial affiliations.
E.F., a 40-year-old woman, comes to your office for a routine gynecologic visit. She is not taking any medications and is generally healthy. She is sexually active, and her last menstrual period started 10 days ago. She tells you that her mother was diagnosed with bilateral breast cancer at 49 years of age and that she would like to discuss her options for reducing the risk of breast cancer.
Case Study Questions
1. According to the U.S. Preventive Services Task Force (USPSTF) recommendation on medication use to reduce risk of breast cancer, who should be offered risk-reducing medications?
A. A 40-year-old woman with a first-degree relative with breast cancer.
B. A 50-year-old woman with a first-degree relative who developed breast cancer at 55 years of age.
C. A 40-year-old woman with a 5% risk of developing breast cancer in the next five years.
D. A 50-year-old woman with a second-degree relative with bilateral breast cancer.
E. A 60-year-old woman with a 1% risk of developing breast cancer in the next five years.
2. Based on her increased risk for breast cancer, E.F. decides to take a risk-reducing medication. Which one of the following is the most appropriate next step for the physician?
A. Offer the patient raloxifene (Evista).
B. Offer the patient tamoxifen.
C. Offer the patient anastrozole.
D. Offer the patient exemestane.
E. Do not offer any medications.
3. Which of the following statements are correct about the harms of risk-reducing medications?
A. The use of tamoxifen is associated with an increased risk of endometrial cancer.
B. The use of raloxifene is associated with an increased risk of fractures.
C. Both tamoxifen and raloxifene are associated with an increased risk of thromboembolic events.
D. All risk-reducing medications are associated with an increased risk of vasomotor and musculoskeletal symptoms.
1. The correct answer is C. The USPSTF recommends that clinicians offer to prescribe risk-reducing medications to asymptomatic women at increased risk
1. Davidson KW, Krist AH, Barry MJ, et al. Medication use to reduce risk of breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2019;322(9):857–867.
2. Nelson HD, Fu R, Zakher B, et al. Medication use for the risk reduction of primary breast cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;322(9):868–886.
This PPIP quiz is based on the recommendations of the USPSTF. More information is available in the USPSTF Recommendation Statement and supporting documents on the USPSTF website (https://www.uspreventiveservicestaskforce.org). The practice recommendations in this activity are available at https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction1.
This series is coordinated by Kenny Lin, MD, MPH, deputy editor.
A collection of Putting Prevention into Practice published in AFP is available at https://www.aafp.org/afp/ppip.
Copyright © 2020 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions